Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Filters applied: . Clear all
Page 1
Carbonic Anhydrase IX: A Renewed Target for Cancer Immunotherapy.
Campos NSP, Souza BS, Silva GCPD, Porto VA, Chalbatani GM, Lagreca G, Janji B, Suarez ER. Campos NSP, et al. Cancers (Basel). 2022 Mar 9;14(6):1392. doi: 10.3390/cancers14061392. Cancers (Basel). 2022. PMID: 35326544 Free PMC article. Review.
CAIX expression is restricted to a few sites in healthy tissues, positioning this molecule as a strategic target for cancer immunotherapy. In this review, we summarized preclinical and clinical data of immunotherapeutic strategies based on monoclonal antibodies (mAbs), fus …
CAIX expression is restricted to a few sites in healthy tissues, positioning this molecule as a strategic target for cancer immunothe …
CMTM6 and CMTM7: New leads for PD-L1 regulation in breast cancer cells undergoing EMT.
Xiao M, Duhem C, Chammout A, Berchem G, Janji B. Xiao M, et al. J Cell Biochem. 2022 Jun;123(6):1025-1031. doi: 10.1002/jcb.30273. Epub 2022 May 16. J Cell Biochem. 2022. PMID: 35575054 Free PMC article.
Programmed death-ligand 1 (PD-L1) expression has long been used as a biomarker to stratify patients with cancer who will benefit from anti-PD-1/PD-L1 immunotherapy. However, the use of PD-L1 as a biomarker to guide treatment decisions has recently been called into question …
Programmed death-ligand 1 (PD-L1) expression has long been used as a biomarker to stratify patients with cancer who will benefit from …